Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!

Published:2010-06 Issue:6 Volume:35 Page:524-526
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Amaral Leonard,Boeree Martin J.,Gillespie Stephen H.,Udwadia Zarir F.,van Soolingen Dick

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference15 articles.

1. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review;Faustini;Thorax,2006

2. The emergence of drug-resistant tuberculosis in New York City;Frieden;N Engl J Med,1993

3. Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995–1997;Munsiff;Emerg Infect Dis,2002

4. World Health Organization. Anti-tuberculosis drug resistance in the world. Report No. 4. Geneva, Switzerland: WHO; 2008.

5. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective;Perdigão;Microb Drug Resist,2008

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive/ sensitive Leishmania donovani promastigotes and intracellular amastigotes;Experimental Parasitology;2024-02

2. Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade;ACS Omega;2023-05-10

3. Resistance in Tuberculosis: Molecular Mechanisms and Modulation;Integrated Science;2023

4. The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis;Drugs;2022-12

5. Antituberculosis Drug Repurposing: A New Hope for Tackling Multi-Challenging TB in Timely Manner;Drug Repurposing - Molecular Aspects and Therapeutic Applications;2022-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3